Research.Patient.info
Waldenström Macroglobulinemia (WM) research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE2
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
This study is testing a new medicine called acalabrutinib for people with Waldenström Macroglobulinemia (WM). It aims to see how safe the medicine is, how it works in the body, and if it helps treat WM, a type of blood cancer.
United States · France · Greece - recruitingPHASE1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
This study is testing a new medicine, NX-5948, for adults with certain types of blood cancer that have come back or not responded well to previous treatments. It aims to find out if the medicine is safe and helps fight the cancer, starting with small doses and gradually increasing.
United States · France · Italy